After Symyx Terminates Acquisition Discussions, Certara Submits Proposal for $5.75 per Share
June 18, 2010
After Symyx Terminates Acquisition Discussions, Certara Submits Proposal for $5.75 per Share
The new offer, worth around $200 million, comes as Symyx prepares to finalize its previously disclosed merger with Accelrys, which values Symyx at $178 million.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Accelrys Completes Merger with Symyx; Will Cut up to 15 Percent of Combined Workforce
July 2, 2010 / BioInform - Symyx Spurns Certara's $5.75-per-Share Offer Twice in One Week
June 25, 2010 / BioInform - Symyx in Discussions with New Suitor after Bidding Climbs to $6.75 Per Share
May 28, 2010 / BioInform - Accelrys to Tailor NGS Software for Oxford Nanopore Sequencer
March 18, 2011 / BioInform - Linguamatics to Integrate I2E Text-Mining Software with Accelrys' Pipeline Pilot
September 17, 2010 / BioInform